Fennec Pharmaceuticals to Announce Q1 2024 Financial Results on May 14

RESEARCH TRIANGLE PARK, N.C., May 07, 2024 – Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a company specializing in commercial-stage pharmaceuticals, has announced plans to release its financial results for the first quarter of 2024. This announcement is scheduled for Tuesday, May 14, 2024, before the U.S. financial markets open. On the same day, the company will hold a conference call and webcast to discuss its financial and business performance.

The conference call is set for 8:30 a.m. Eastern Time. Interested parties can register for the call by visiting https://register.vevent.com/register/BI137d97d6710341398d6f17d0433dc5b8. Upon completing the registration, participants will receive a dial-in number and a unique PIN to access the call. Additionally, the company will provide a live webcast, accessible through its website at www.fennecpharma.com. Attendees are advised to log onto the website at least 15 minutes before the event to allow time for any necessary software downloads. After the call, a replay of the webcast will be available on the company’s website for 30 days.

Fennec Pharmaceuticals Inc. is known for its work on PEDMARK® and PEDMARQSI®, two products aimed at minimizing the risk of ototoxicity caused by platinum-based chemotherapy in pediatric patients. PEDMARK received approval from the FDA in September 2022, and the European Commission granted marketing authorization for PEDMARQSI in June 2023. In addition, PEDMARQSI was approved in the U.K. in October 2023. PEDMARK benefits from Orphan Drug Exclusivity in the U.S., providing seven years of market protection, while PEDMARQSI has Pediatric Use Marketing Authorization in Europe, which includes eight years plus an additional two years of data and market protection.

How to obtain the latest research advancements in the field of biopharmaceuticals?

In the Synapse database, you can keep abreast of the latest research and development advances in drugs, targets, indications, organizations, etc., anywhere and anytime, on a daily or weekly basis. Click on the image below to embark on a brand new journey of drug discovery!